Stock research tool

Stock research, the way pros do it

Eight valuation lenses (Buffett, Graham, Lynch, Greenblatt). Eight quality scorecards (Piotroski, Altman). Live options chain. Multi-source technicals with breakout detection. Per-symbol trading journal. One page per ticker — free to browse on any stock.

What's on every symbol page

8 valuation lenses per stock

Buffett owner-earnings DCF, Graham Number, Lynch PEG, Greenblatt Magic Formula, Greenwald Earnings Power Value, reverse DCF, Dividend Discount Model, sell-side consensus. Each lens shows the inputs, the verdict, and how it disagrees with the others.

8 quality scorecards

Piotroski F-score, Altman Z-score, profitability, Sloan accrual quality, balance-sheet solvency, dividend safety, capital efficiency, moat proxy. Composite 0–100 score per holding rolls them up.

Multi-source technicals

Daily RSI, MACD, SMA 50/200, support and resistance levels, breakout state (active / approaching / consolidation), volume confirmation, ATR-based stop and target suggestions. Data routes through yfinance → Twelve Data fallback so a single rate-limit doesn't blank the page.

Live options chain

Full options chain with bid/ask, mark, volume, open interest, implied volatility, and per-leg Greeks (delta, gamma, theta, vega). Filter by DTE, strike distance, volume. Multi-leg builder for verticals, strangles, iron condors.

Breakouts + signals

Real-time breakout detection over your watchlist. Top active signals (RSI divergence, MA cross, volume surge, channel break, double-top forming) surfaced as small chips on every card.

Peer comparison

Side-by-side fundamentals + valuation + quality against sector peers. Surface the cheapest, the highest quality, and the most overpriced in one glance.

Dividend history + projections

Trailing payment history, current yield, yield-on-cost, payout ratio, DRIP impact. 12-month forward calendar so income investors can plan.

Per-symbol trading journal

Log a thesis, entry rationale, post-mortem, screenshots, R-multiple. Filter by win rate or strategy. Works on any ticker, even one you don't currently hold.

Price chart with period selector

1M / 3M / 6M / 1Y / 5Y / MAX daily-close charts. Compare against SPY, QQQ, or the home-country index. Currency-converted to your default so a Stockholm-listed stock shows in CAD or USD.

Multi-exchange + cross-listings

TSX / NYSE / NASDAQ / LSE / TSE / SIX / HKEX coverage with auto-detected currency. Cross-listed tickers (e.g. RY.TO ↔ RY) surface side by side.

Fundamentals snapshot

P/E, P/S, P/B, ROE, ROIC, FCF margin, debt/equity, current ratio, revenue + earnings growth, share-count history. All updated daily.

Risk overlay

Beta to SPY, 30-day historical volatility, max drawdown, position concentration if held, sector exposure, correlation with the rest of your portfolio.

Built for the way investors actually research

Most stock research tools ask you to pick one philosophy. Pick the DCF crowd and you lose the Graham margin-of-safety perspective. Pick a momentum tool and you miss the fundamentals. WealthWatch shows all eight valuation lenses side-by-side on every symbol — Warren Buffett's owner-earnings DCF next to Benjamin Graham's defensive Graham Number, Peter Lynch's growth-adjusted PEG ratio, Joel Greenblatt's Magic Formula rank, Bruce Greenwald's earnings power value, plus reverse DCF, dividend discount, and sell-side consensus. You see when they agree (cheap across the board, likely undervalued) and when they disagree (Lynch says cheap, Graham says expensive — go figure out why).

The same applies to quality. A 9-point Piotroski F-score proxy flags fundamental weakness; an Altman Z-score proxy flags bankruptcy risk; Sloan-accrual quality flags earnings that don't convert to cash. Six other scorecards (profitability, debt, dividend safety, growth consistency, capital efficiency, moat proxy) round out the picture. The composite 0–100 score is a single number you can sort by, but the individual components are always one click away.

Options traders get a live chain with full per-leg Greeks, a multi-leg builder for verticals / strangles / iron condors / calendars, an IV-rank screener, and pin-risk scans for short positions near expiry. Stock and options share one journal: log a thesis, record the entry, attach a screenshot, and the post-mortem writes itself when the position closes.

Frequently asked

Is the stock research tool free?

Fundamentals, price chart, dividend history, and basic technicals are free — no account needed. Valuation lenses, quality scorecards, multi-leg options builder, peer comparison, and the trading journal require a WealthWatch Pro subscription ($5/month USD).

Which exchanges does it cover?

NYSE, NASDAQ, AMEX, TSX, TSXV, LSE, Frankfurt, Stockholm, Tokyo, Hong Kong, Swiss, Australian. Auto-detected from the ticker, with currency conversion to your home currency on every row.

Where does the valuation data come from?

Fundamentals (FCF, EPS, ROE, growth, debt, dividends, shares outstanding) come from yfinance with a 12-hour cache. Quote prices route through a multi-source chain (yfinance → Twelve Data → daily-bar cache) so a single provider rate-limit doesn't blank the page.

How accurate are the valuation models?

Treat them as one input, not as a price target. Each model has known weaknesses — DCFs are sensitive to terminal growth assumptions, Graham Number assumes a defensive value style. We show all 8 side-by-side and surface the median fair value + the cheap/fair/expensive count so you can spot when one model is an outlier.

Can I research stocks I don't own?

Yes. Open /symbol/AAPL (or any ticker) and you get the full research view whether or not the stock is in your portfolio. The Per-symbol journal also lets you log a thesis on a stock you're considering — without forcing you to "add to watchlist" first.

Are the options Greeks live?

Greeks (delta, gamma, theta, vega) refresh on each page load using the latest chain quotes. They're not a streaming feed — for sub-second updates use your broker — but they're fresh enough for position management, scenario planning, and pin-risk scans.

Pick any ticker. Get the full research view.

Browsing is free. The deep lenses + journal unlock with Pro at $5/month.